Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults

NCT02547792 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza B

Interventions

BIOLOGICAL: VXA-BYW.10 (Low Dose) Oral Vaccine
BIOLOGICAL: VXA-BYW.10 (High Dose) Oral Vaccine
OTHER: Placebo Tablets

Sponsor

Vaxart